Ap24
AMENDMENT
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
| Name of exempt principal trader | J.P. Morgan Securities Plc |
| Company dealt in | UDG Healthcare Plc |
| Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
| Date of dealing | 2 July 2021 |
2. DEALINGS (Note 2)
(a) Purchases and sales
| Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
| 373,118 | 10.7000 GBP | 10.6798 GBP |
| Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
| 153,976 | 10.7100 GBP | 10.6600 GBP |
(b) Derivatives transactions (other than options transactions)
| Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
| Equity Swap | Decrease Long
Decrease Short
Increase Long
Increase Short
Opening a long position
Opening a short position
| 241 340 439 1,491
20 3,127 11,187 408
5,948 12,553 134
75,000 25,000 4,784 112,900
34,785 4,953 5,639 4,162 10,710 4,922
25,554 14,077 1,201 850 4,851 9,043 3,384 4,592 1,635
| 10.6864 GBP 10.6865 GBP 10.6902 GBP 10.6995 GBP
10.6900 GBP 10.6905 GBP 10.6957 GBP 10.7039 GBP
10.6798 GBP 10.6852 GBP 10.6992 GBP
10.6802 GBP 10.6832 GBP 10.6879 GBP 10.7030 GBP
10.6800 GBP 10.6831 GBP 10.6852 GBP 10.6891 GBP 10.6894 GBP 10.6969 GBP
10.6800 GBP 10.6805 GBP 10.6901 GBP 10.6906 GBP 10.6912 GBP 10.6920 GBP 10.6951 GBP 10.6957 GBP 10.7001 GBP
|
Ap25
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
| Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
|
|
|
|
|
|
|
|
(ii) Exercising
| Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
|
|
|
|
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
| Date of disclosure | 28 July 2021 |
| Contact name | Alwyn Basch |
| Telephone number | 020 7742 7407 |
| Name of offeree/offeror with which connected | UDG Healthcare Plc |
| Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
